Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.33%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 7.08Close
$ 2.22 - $ 7.34 52-Week Range
Ticker Information
Ticker
AQSTCompany Name
AQUESTIVE THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQAQUESTIVE THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
AQST - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 585K | 1.33% | $ 44.13M |
| 3/31/2025 | $ 650K | 1.2% | $ 54.23M |
| 12/31/2024 | $ 718K | 1.25% | $ 57.56M |
| 9/30/2024 | $ 1.04M | 1.76% | $ 58.9M |
| 6/30/2024 | $ 1.14M | 1.96% | $ 58.36M |
| 3/31/2024 | $ 1.23M | 2.38% | $ 51.5M |
| 12/31/2023 | $ 1.34M | 2.66% | $ 50.58M |
| 9/30/2023 | $ 1.27M | 2.65% | $ 48.06M |
| 6/30/2023 | $ 1.61M | 3.45% | $ 46.52M |
| 3/31/2023 | $ 1.99M | 4.26% | $ 46.54M |
Key Performance Insights, Last 5 Years
- AQUESTIVE THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 5.55%.
- Over the past 5 years, AQUESTIVE THERAPEUTICS INC's average DepAmor % has been 4.28%.
- The median DepAmor % for AQUESTIVE THERAPEUTICS INC during this period was 4.64%
- AQUESTIVE THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 7.78%.
- The lowest DepAmor % recorded by AQUESTIVE THERAPEUTICS INC in the same timeframe 1.2%
AQUESTIVE THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for AQUESTIVE THERAPEUTICS INC is calculated as follows: DepAmor [ $ 3.06M ] / Revenues [ $ 55.12M ]
(=) DepAmor % [ 5.55% ] AQST - Depreciation and Amortization Margin, Last 5 years
1.2%
Minimum
Mar 31, 2025
7.78%
Maximum
Jun 30, 2021
4.28%
Average
4.64%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |